2,148 results on '"Mathews, Anna Wilde"'
Search Results
2. Walgreens Plans Major U.S. Store Closures; Shares Tumble.
3. Kaiser Permanente Unit to Acquire North Carolina Hospital System.
4. Medicare Will Recalculate Quality Ratings of Medicare Advantage Plans.
5. Exclusive | NewYork-Presbyterian Hospital System Demanded $25 Million to Stay Out of a Union's Health Insurance Plan.
6. CVS Made a Big Bet on Medicare. It's Looking Risky.
7. UnitedHealth Stock Jumps After Earnings Beat Expectations, Despite Cyberattack.
8. Wegovy: First Medicare Health Plans to Start Paying for Weight-Loss Drug.
9. J&J Accused of Mismanaging Its Employees' Drug Benefits.
10. CVS, Walgreens to Sell Abortion Pill Mifepristone Within Weeks.
11. Cigna Sells Medicare Business to Health Care Service Corp. for $3.3 Billion.
12. Humana Reports Steep Losses, Signals More Trouble for Next Year.
13. Cigna Nears Deal to Offload Medicare Business.
14. CVS Plans to Overhaul How Much Drugs Cost.
15. Cigna, Humana in Talks for Blockbuster Insurance Merger in Stock-and-Cash Deal.
16. Health Inflation's Big Hike This Year, in Charts.
17. Pharmacy Giant Walgreens Names Tim Wentworth as New CEO.
18. Bayer is asked to suspend Trasylol sales
19. Novartis drug approved by EU
20. Sequel for Vioxx critic: attack on diabetes pill; Glaxo shares plunge as Dr. Nissen sees risk to heart from Avandia
21. Sanofi's bird-flu vaccine is granted FDA approval: first human treatment is seen as stopgap aid as research continues
22. Sleep drugs get warning on labels sought by FDA
23. Firms study drugs to help avert diabetes
24. Reading fine print, insurers question studies of drugs
25. A death prompts withdrawal of promising MS drug; are too many unproven drugs receiving FDA early approval? Process comes under scrutiny
26. Merck, Pfizer face advertising obstacle; if Vioxx, Celebrex return, the drugs' promotion will be a difficult task
27. FDA panel weighs array of options on painkillers
28. Painkiller panel gets few answers; drug makers, researchers fail to agree on the risks, proper use of the medicine
29. Why U.S., Canada differ on safety of attention-deficit drug
30. FDA Safety Office, FCC to get boost as SEC funding is stable
31. Second opinion: as drug safety concerns grow, looking overseas for solutions
32. U.S. plans broad painkiller review; health officials to focus on side effects, with eye toward regulatory action
33. Celebrex drama may finally prompt changes at the FDA
34. As safety issues hit Celebrex, Pfizer decides to hang tough; drug giant will halt ads, but continue selling its widely used painkiller
35. Medical journal seeks FDA overhaul
36. FDA official assails agency on monitoring of risks; at hearing on Vioxx recall, safety expert cites lapses, and points to other drugs
37. Merck documents show Vioxx tension
38. Did FDA staff mimize Vioxx's red flags?
39. FDA plans major review of procedures
40. E-mails suggest Merck knew Vioxx's dangers at early stage; as signs of heart risk rose, officials played hardball; trainees are told 'dodge'
41. New Vioxx study projects cases of heart attacks
42. Vioxx recall raises questions on FDA's safety monitoring
43. Expiration date: Merck pulls Vioxx from market after link to heart problems; drug's demise raises concerns about company's future; loss of $2.5 billion in sales' patients are left in quandary
44. FDA will warn on antidepressants; labels will say the drugs increase youth suicide risk; 'black box' alert considered
45. Congress to air controversies over drug trials
46. Big HMO reconsiders Vioxx after study points to heart risks
47. FDA wll seek to revise Labels for antidepressants
48. Medicare battle causes headaches; proposed drug guidelines to intensify industry fight; manufacturers vs. insurers
49. FDA revisits issue of antidepressants for youths; new analysis may pressure agency to set limit on use because of suicide risk
50. Invasive procedure: after Medtronic lobbying push, the FDA had change of heart; agency squelches an article raising doubts on safety of device to repair artery; threat of 'criminal sanction'
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.